Jun Wang

Pharmaceutical Sciences State University of New York, Buffalo, Buffalo, NY, United States 
"Jun Wang"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Greene MK, Chen T, Robinson E, et al. (2020) Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer. British Journal of Cancer
Wang J, Chan DK, Sen A, et al. (2019) Tumor priming by SMO inhibition enhances antibody delivery and efficacy in a pancreatic ductal adenocarcinoma model. Molecular Cancer Therapeutics
Ci LQ, Huang ZG, Lv FM, et al. (2019) Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics. 11
Huang ZG, Lv FM, Wang J, et al. (2018) RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability. International Journal of Pharmaceutics
Chan D, Minx C, Wang J, et al. (2018) Abstract 3704: Efficacy of DR5-targeted immunoliposomes in pancreatic cancer models primed with SMO inhibitors Cancer Research. 78: 3704-3704
Wang J, Qu Y, Pitoniak R, et al. (2014) Abstract 2691: Smo-targeted sonic hedgehog signaling inhibitor enhances therapeutic antibody deposition and efficacy in a patient-derived pancreatic ductal adenocarcinoma model Cancer Research. 74: 2691-2691
Su MY, Samoszuk MK, Wang J, et al. (2002) Assessment of protamine-induced thrombosis of tumor vessels for cancer therapy using dynamic contrast-enhanced MRI. Nmr in Biomedicine. 15: 106-13
See more...